In
2018, an estimated 3,714 Texans will be diagnosed with liver and intrahepatic
bile duct cancer. An estimated 2,532 Texans will die from it. Liver and
intrahepatic bile duct cancer is the sixth most common cause of cancer death in
Texas.
Liver
and intrahepatic bile duct cancer is associated with modifiable risk factors,
including chronic hepatitis B virus or hepatitis C virus infections, liver cirrhosis, tobacco use, obesity and diabetes. As many as 63%
of cases can be attributed to modifiable risk factors.
In
Texas, the incidence rate for this cancer in adults ages 25 years and older has
significantly increased by an average of 3.9% per year. In 2001, the incidence
rate was 9.3 cases per 100,000; it had increased to 16.6 cases per 100,000 in
2015. During the same time period, the US rate increased by an average of 3.8%
per year. In 2015, Texas had the highest incidence rate and fourth highest mortality
rate of all US states.
Liver
and intrahepatic bile duct cancer has low survival. Compared to Texans without
cancer, only 15.6% of Texans survive for five years after being diagnosed with
liver and intrahepatic bile duct cancer.
This
statistical report describes incidence and mortality rates for liver and
intrahepatic bile duct cancer in Texas. It replicates some of the analyses
described in a recent publication on trends in liver and intrahepatic bile duct
cancer mortality in the United States.1 To quantify rates and trends of liver and intrahepatic bile duct cancers
from 2001-2015, age-adjusted incidence and mortality rates were calculated for Texans
ages 25 years and older by sex, age and race/ethnicity.
The
accompanying two-page summary shows information on liver and intrahepatic bile
duct cancer incidence, mortality, risk factors, prevalence, and relative
survival.
Liver and Intrahepatic Bile Duct Cancer Footnote| 1 Xu, J. (2018). Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000-2016. NCHS Data Brief, No.314. |
Back to Cancer Statistics
Contact TCR